Search company, investor...

Total Raised

$920K

Investors Count

2

Deal Terms

1

Funding, Valuation & Revenue

2 Fundings

Carbon Nanoprobes has raised $920K over 2 rounds.

Carbon Nanoprobes's latest funding round was a Series A for $0.86M on December 20, 2007.

Carbon Nanoprobes's latest post-money valuation is from December 2007.

Sign up for a free demo to see Carbon Nanoprobes's valuations in December 2007 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/20/2007

Series A

$0.86M

$99M

0

FY undefined

5/15/2007

Angel

$99M

$99M

0

FY undefined

0

Date

12/20/2007

5/15/2007

Round

Series A

Angel

Amount

$0.86M

$99M

Investors

Valuation

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

Sources

0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Carbon Nanoprobes Deal Terms

1 Deal Term

Carbon Nanoprobes's deal structure is available for 1 funding round, including their Series A from December 20, 2007.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Carbon Nanoprobes Investors

2 Investors

Carbon Nanoprobes has 2 investors. Life Sciences Greenhouse of Central Pennsylvania invested in Carbon Nanoprobes's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/20/2007

12/20/2007

1
Series A

Corporation

Pennsylvania

00/00/0000

00/00/0000

Alliance of Angels

Subscribe to see more

Angel Investor (Group)

Washington

First funding

12/20/2007

00/00/0000

Last Funding

12/20/2007

00/00/0000

Investor

Alliance of Angels

Rounds

1
Series A

Subscribe to see more

Board Seats

Type

Corporation

Angel Investor (Group)

Location

Pennsylvania

Washington

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Carbon Nanoprobes to Competitors

P
Princeton Fusion Systems

Princeton Fusion Systems is a company focused on fusion research and power electronics in the energy sector. The company's main offering is the development of compact fusion reactors, which are portable units designed to provide power in the range of 1 to 10 MW and can be installed anywhere. It is based in Plainsboro, New Jersey.

P
Powerspan

Powerspan develops and markets clean energy technologies for the electric power industry. Powerspan offers its patented ECO multi-pollutant control process.

SurgeonsLab Logo
SurgeonsLab

Surgeon's Lab provides technology to train and educate neurosurgeons and interventional neuroradiologists of all levels. It develops and produces patient-specific training models for training surgical procedures and validating new medical devices. It was founded in 2021 and is based in Bern, Switzerland.

Blaze Systems Logo
Blaze Systems

Blaze Systems specializes in laboratory information management systems (LIMS) within the software industry. The company offers a comprehensive suite of LIMS solutions designed to automate laboratory operations, manage resources, and ensure regulatory compliance. Blaze Systems primarily serves sectors such as biotechnology, clinical labs, manufacturing, and pharmaceuticals. It was founded in 1991 and is based in Newark, Delaware.

K
Kryosphere

Kryosphere is a full-service biorepository company operating in the biotechnology industry. The company's main services include managing, storing, and transporting biological and pharmaceutical materials, as well as providing cold chain logistics, clinical trial management, and stability storage services. Kryosphere primarily serves sectors such as academia, biopharmaceuticals, bioagriculture, and clinical research. It was founded in 2007 and is based in Durham, North Carolina.

I
Informed Medical Communications

Informed Medical Communications specializes in providing communication and documentation solutions within the healthcare sector. Their main offerings include software tools that facilitate clear and efficient documentation and communication between healthcare facilities, patients, and their responsible parties. These tools are designed to educate and inform about patient conditions and assist in managing healthcare provider relationships. It is based in New York, New York.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.